Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is O  [Clear All Filters]
Journal Article
Ng, W.L., Chen, G., Wang, M., Wang, H., Story, M., Shay, J.W., Zhang, X., Wang, J., Amin, A.R.M.R., Hu, B., et al. (2014). OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.Cell Death Dis5, e1024.
Wu, G., Wilson, G., Zhou, G., Hebbard, L., George, J., and Qiao, L. (2015). Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma.Discov Med20, 219-229.
Deveale, B., Brokhman, I., Mohseni, P., Babak, T., Yoon, C., Lin, A., Onishi, K., Tomilin, A., Pevny, L., Zandstra, P.W., et al. (2013). Oct4 is required ∼e7.5 for proliferation in the primitive streak.Plos Genet9, e1003957.
Tsai, L.-L., Hu, F.-W., Lee, S.-S., Yu, C.-H., Yu, C.-C., and Chang, Y.-C. (2014). Oct4 Mediates Tumor Initiating Properties in Oral Squamous Cell Carcinomas through the Regulation of Epithelial-Mesenchymal Transition.Plos One9, e87207.
Kim, S.Jin, Koo, O.Jae, Park, H.Jung, Moon, J.Ho, da Torre, B.Roibas, Javaregowda, P.Kanive, Kang, J.Taek, Park, S.Ji, Saadeldin, I.M., Choi, J.Yei, et al. (2014). Oct4 overexpression facilitates proliferation of porcine fibroblasts and development of cloned embryos.Zygote1-8.
Tao, Y., Liu, X., Cui, L., Liu, X., Chen, Y., He, Z., Ji, M., Gao, Z., Li, N., Wan, Z., et al. (2020). Oct4 plays a role in 2, 3, 7, 8 - tetrachlorobenzo-p-dioxin (TCDD) inducing cleft palate and inhibiting mesenchymal proliferation.Toxicology152444.
Zeineddine, D., Hammoud, A.Abou, Mortada, M., and Boeuf, H. (2014). The Oct4 protein: more than a magic stemness marker.Am J Stem Cells3, 74-82.
Wen, K.-M., Zhang, G.-H., Li, J., Chen, Z.-Q., Cheng, Y.-L., Su, X., and Zeng, Q.-L. (2015). OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to οxaliplatin in colon cancer.Oncol Rep.
Chen, Y., Wu, Z., Zhu, X., Zhang, M., Zang, X., Li, X., and Xu, Y. (2019). OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6.Exp Neurol.
Li, R., Vannitamby, A., Zhang, J.-G., Fehmel, E.L., Southwell, B.R., and Hutson, J.M. (2015). Oct4-GFP expression during transformation of gonocytes into spermatogonial stem cells in the perinatal mouse testis.J Pediatr Surg.
Alabdi, L., Saha, D., He, M., Dar, M.Saleem, Utturkar, S.M., Sudyanti, P.Ayu, McCune, S., Spears, B.H., Breedlove, J.A., Lanman, N.A., et al. (2020). Oct4-Mediated Inhibition of Lsd1 Activity Promotes the Active and Primed State of Pluripotency Enhancers.Cell Rep30, 1478-1490.e6.
Chai, S., Ng, K.-Y., Tong, M., Lau, E.Y., Lee, T.K., Chan, K.Wah, Yuan, Y.-F., Cheung, T.-T., Cheung, S.-T., Wang, X.-Q., et al. (2016). Oct4/miR-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells.Hepatology.
Zimmerman, D.L., Boddy, C.S., and Schoenherr, C.S. (2013). Oct4/Sox2 binding sites contribute to maintaining hypomethylation of the maternal igf2/h19 imprinting control region.Plos One8, e81962.
Zorin, V.L., Komlev, V.S., Zorina, A.I., Khromova, N.V., Solovieva, E.V., Fedotov, A.Yu, Eremin, I.I., and Kopnin, P.B. (2014). Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts.Biomed Mater9, 055005.
Ko, D.Sung, Lee, D.Ryul, Song, H., Kim, J.-H., and Lim, C.Kyu (2019). Octylphenol and nonylphenol affect decidualization of human endometrial stromal cells.Reprod Toxicol.
Singh, P., Tyagi, M., Kumar, Y., Gupta, K.K., and Sharma, P.D. (2013). Ocular chemical injuries and their management.Oman J Ophthalmol6, 83-86.
Felder-Schmittbuhl, M.-P., Buhr, E.D., Dkhissi-Benyahya, O., Hicks, D., Peirson, S.N., Ribelayga, C.P., Sandu, C., Spessert, R., and Tosini, G. (2018). Ocular Clocks: Adapting Mechanisms for Eye Functions and Health.Invest Ophthalmol Vis Sci59, 4856-4870.
Nassiri, N., Eslani, M., Panahi, N., Mehravaran, S., Ziaei, A., and Djalilian, A.R. (2013). Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations.J Ophthalmic Vis Res8, 351-358.
Balasubramaniam, S.C., Raja, H., Nau, C.B., Shen, J.F., and Schornack, M.M. (2015). Ocular Graft-Versus-Host Disease: A Review.Eye Contact Lens.
Inamoto, Y., Valdés-Sanz, N., Ogawa, Y., Alves, M., Berchicci, L., Galvin, J., Greinix, H., Hale, G.A., Horn, B., Kelly, D., et al. (2018). Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.Biol Blood Marrow Transplant.
Fenzl, C.R., Teramoto, K., and Moshirfar, M. (2015). Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.Clin Ophthalmol9, 1633-1644.
Nassar, A., Tabbara, K.F., and Aljurf, M. (2013). Ocular manifestations of graft-versus-host disease.Saudi J Ophthalmol27, 215-22.
Sulyok, M., Rózsa, L., Bodó, I., Tappe, D., and Hardi, R. (2014). Ocular Pentastomiasis in the Democratic Republic of the Congo.Plos Negl Trop Dis8, e3041.
Dhamodaran, K., Subramani, M., Ponnalagu, M., Shetty, R., and Das, D. (2014). Ocular stem cells: a status update!.Stem Cell Res Ther5, 56.
Lam, J., Wong, T.T., and Tong, L. (2015). Ocular surface disease in posttrabeculectomy/mitomycin C patients.Clin Ophthalmol9, 187-191.

Pages